hauptversammlung der carl zeiss meditec ag...hauptversammlung der carl zeiss meditec ag author: dr....

Annual General Meeting

Carl Zeiss Meditec AG

30 May 2017, JenaDr. Ludwin Monz, President and CEO

230 May 2017Annual General Meeting of Carl Zeiss Meditec AG, Dr. Ludwin Monz

Thank you!

To all our employees and…. my management colleagues


Thank you!

To all members of the Supervisory Board


Our customers - Partners in the development of new products


Making blood flow visible

Prof. Dr. Andreas Raabe is the Director and Senior Consultant of the Department of Neurology at Bern University Hospital (Inselspital).

Professor Dr. Andreas Raabe in an interview with Dr. Ludwin Monz


Prof. Dr. Andreas Raabe is the Director and Senior Consultant of the Department of Neurology at Bern University Hospital (Inselspital).

“What we want is absolutely clear: the best image!”

Professor Dr. Andreas Raabe in an interview with Dr. Ludwin Monz

Annual General Meeting 2017



Market-changing innovation in ophthalmology

IOLMaster ® 700

Contactless measurement of the eyeball More than 100 million eyes measured worldwide


ZEISS AngioPlex enables a non-invasive examination of the eye


Setting new standards - Visualization using fluorescence

OPMI® Pentero® 900


Setting new standards – Robotic visualization system with intelligent assistance functions

KINEVO 900


Better results, also from functional and esthetic perspective

EXTARO 300


Digitization means new opportunities for our business


Immediate overview of all important information


App-assisted patient communication

Zeiss Connect App


Direct presence in most important medical technology markets

Company locations of the Carl Zeiss Meditec Group

Production, Sales, Service, R&D

Sales and Service locations of the

Carl Zeiss Meditec Group

USA, France, Spain, Germany, Japan, Turkey


Customer proximity - Crucial advantage in international competition

Company locations of the Carl Zeiss Meditec Group

Production, Sales, Service, R&D

Sales and Service locations of the

Carl Zeiss Meditec Group

USA, France, Spain, Germany, Japan, Turkey

Sales and Service locations of the ZEISS Group


Meeting our responsibilities worldwide


1 adjusted for currency effects2 Earnings before interest and tax (EBIT)3 Cash flows from operating activities

Revenue

€1,088m

Growth1

+ 2.7%

EBIT2

€154.3m

EBIT margin

14.2%

Earnings per share

€1.21

Cash flow3

€111.8m

Successful trend of past few years continuesFiscal year 2015/16


Revenue

€791.9m

Growth1

+ 4.1 %

Proportion of revenue

72.8 %

Diagnosis After-careTreatment

Ophthalmic DevicesStrong contribution to positive business development

1 Adjusted for currency effects


Revenue

€296.5m - 0.9%


27.2 %

Visualization solutions for minimally invasive surgical treatments

MicrosurgeryStable organic growth trend

Growth1



EMEA

Americas

APAC

Revenue

€352.7m

Growth1

- 1.3 %


32.4 %

€354.0m - 4.9 % 32.5 %

€381.7m + 15.5 % 35.1 %

APAC region with highest contribution to growth



60%

80%

100%

120%

140%

160%

180%

04.01.2016 04.01.2017

Price €45.361)

+ 60 %~ €4bn

HistoryMarket cap

+ 25 %History

Carl Zeiss Meditec AG share

TecDAX

Very good performance of Carl Zeiss Meditec AG share

1) Closing rate Xetra 29 May 2017


Dividend

€0.42

Dividend ratio

35 %

Proposed dividend


Issue price

€38.94

Funds accrued1)

€317m

Number of shares89,440,570

8.1 million shares successfully placed

1) Before incidental costs


Revenue

€587.5m

Growth1

+ 7.1 %

EBIT

€91.5m

EBIT margin

16.2 %

Continuing on road to successH1 2016/17



Growth1 Ophthalmic Devices

+ 9.2 %

Growth1 Microsurgery

+ 1.8 %

Continuing on road to successH1 2016/17



- 0.6%1) + 2.7 %1) + 18.4%1)

EMEA APACAmericas

Greatest impetus for growth from APAC region



Revenue

€1.15 - 1.20bn

EBIT margin

13% - 15%

Projections for fiscal year 2016/17

Annual General Meeting


30 May 2017, JenaDr. Ludwin Monz, President and CEO

hauptversammlung der carl zeiss meditec ag...hauptversammlung der carl zeiss meditec ag author: dr....

Documents